Literature DB >> 24876209

Mistaken identity: normotensive scleroderma renal crisis.

Arwa Aburizik1, Siddharth Singh2, Laith Al-Rabadi1, Christopher Blosser3.   

Abstract

A patient presented with neuromuscular, respiratory and cardiac symptoms and was initially diagnosed with amyotrophic lateral sclerosis (ALS), myocardial ischaemia and pneumonia. He developed unexplained progressive kidney failure over the ensuing week, and his kidney biopsy showed thrombotic microangiopathy that led to the correct diagnosis of normotensive scleroderma renal crisis. His clinical presentation and course were consistent with systemic sclerosis and normotensive scleroderma renal crisis. He was treated with an ACE inhibitor (ACEi) and haemodialysis with significant functional improvement over the next 3 months to his prior baseline with the exception of kidney failure. This case highlights a diagnostic challenge requiring astute history and physical examination skills, and the value of a kidney biopsy in providing the final diagnosis. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24876209      PMCID: PMC4039838          DOI: 10.1136/bcr-2013-202566

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  26 in total

Review 1.  Vascular function in systemic sclerosis.

Authors:  A L Herrick
Journal:  Curr Opin Rheumatol       Date:  2000-11       Impact factor: 5.006

Review 2.  Scleroderma renal crisis.

Authors:  Virginia D Steen
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

Review 3.  Scleroderma renal crisis: new insights and developments.

Authors:  Elisa Y Rhew; Walter G Barr
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

4.  Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade.

Authors:  J A Lopez-Ovejero; S D Saal; W A D'Angelo; J S Cheigh; K H Stenzel; J H Laragh
Journal:  N Engl J Med       Date:  1979-06-21       Impact factor: 91.245

5.  Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.

Authors:  A E Gliddon; C J Doré; C M Black; N McHugh; R Moots; C P Denton; A Herrick; T Barnes; J Camilleri; K Chakravarty; P Emery; B Griffiths; N D Hopkinson; P Hickling; P Lanyon; C Laversuch; T Lawson; R Mallya; M Nisar; C Rhys-Dillon; T Sheeran; P J Maddison
Journal:  Arthritis Rheum       Date:  2007-11

6.  Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans.

Authors:  Matthias Barton
Journal:  Biochim Biophys Acta       Date:  2010-03-30

7.  A case of normotensive scleroderma renal crisis after high-dose methylprednisolone treatment.

Authors:  K Kohno; T Katayama; K Majima; M Fujisawa; S Iida; K Fukami; S Ueda; H Nishida; M Sata; S Kato; M Morimatsu; S Okuda
Journal:  Clin Nephrol       Date:  2000-06       Impact factor: 0.975

8.  Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature.

Authors:  Phuong-Thu T Pham; Phuong-Chi T Pham; Gabriel M Danovitch; H Albin Gritsch; Jennifer Singer; William D Wallace; Rick Hayashi; Alan H Wilkinson
Journal:  Am J Transplant       Date:  2005-10       Impact factor: 8.086

9.  Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases.

Authors:  Y M Traub; A P Shapiro; G P Rodnan; T A Medsger; R H McDonald; V D Steen; T A Osial; S F Tolchin
Journal:  Medicine (Baltimore)       Date:  1983-11       Impact factor: 1.889

10.  Scleroderma renal crisis: patient characteristics and long-term outcomes.

Authors:  H Penn; A J Howie; E J Kingdon; C C Bunn; R J Stratton; C M Black; A Burns; C P Denton
Journal:  QJM       Date:  2007-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.